Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Tax Disclosure [Abstract]
Provision for income tax	$ 16	$ 13	$ 31	$ 28
Effective income tax rate	(0.50%)	(0.20%)	(0.40%)	(0.20%)

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.